Download presentation
Presentation is loading. Please wait.
1
Sharon English Urologist Christchurch
Taking the Wrinkles out of the Bladder The Use of Botulinum Toxin in the Bladder Sharon English Urologist Christchurch
2
After I started botoxing I just could not stop
3
Medical Uses of Botulinum Toxin
blepharospasm pelvic pain strabismus achalasia focal dystonias muscle spasms spasticity wrinkles hyperhidrosis bladder overactivity painful bladder migraine 1949 recognised that Botulinum toxin blocked nerve synapses first medical use in stabismus and blepharospasm
4
Clostridium botulinum spore prior to germination
The lethal dose of botulinum toxin for humans is not known but can be estimated from primate studies. By extrapolation, the lethal amounts of crystalline type A toxin for a 70-kg human would be approximately µg intravenously or intramuscularly, µg inhalationally, and 70 µg orally.10, Therapeutic botulinum toxin represents an impractical bioterrorist weapon because a vial of the type A preparation currently licensed in the United States contains only about 0.3% of the estimated human lethal inhalational dose and 0.005% of the estimated lethal oral dose. All forms of botulism result from absorption of botulinum toxin into the circulation from either a mucosal surface (gut, lung) or a wound. Botulinum toxin does not penetrate intact skin
5
Botulinum Toxin A (Botox®)
7 distinct types Botulinum toxin A,B,C,D,E,F,G Type A and B used in medicine
6
Mechanism of Action of Botulinum Toxin
Figure 1. Mechanism of Action of Botulinum Toxin A, Release of acetylcholine at the neuromuscular junction is mediated by the assembly of a synaptic fusion complex that allows the membrane of the synaptic vesicle containing acetylcholine to fuse with the neuronal cell membrane. The synaptic fusion complex is a set of SNARE proteins, which include synaptobrevin, SNAP-25, and syntaxin. After membrane fusion, acetylcholine is released into the synaptic cleft and then bound by receptors on the muscle cell. B, Botulinum toxin binds to the neuronal cell membrane at the nerve terminus and enters the neuron by endocytosis. The light chain of botulinum toxin cleaves specific sites on the SNARE proteins, preventing complete assembly of the synaptic fusion complex and thereby blocking acetylcholine release. Botulinum toxins types B, D, F, and G cleave synaptobrevin; types A, C, and E cleave SNAP-25; and type C cleaves syntaxin. Without acetylcholine release, the muscle is unable to contract. SNARE indicates soluble NSF-attachment protein receptor; NSF, N-ethylmaleimide-sensitive fusion protein; and SNAP-25, synaptosomal-associated protein of 25 kd.
7
Mechanism of Action of Botulinum Toxin
blocks neuromuscular conduction binds to receptor sites on motor nerve terminals inhibits release of acetylcholine (ACh) Inhibition involves cleavage of SNAP-25, a protein necessary for the release of ACh from vesicles within nerve endings. Results in a partial chemical denervation causing a localised paralysis
8
Regrowth of Axons
9
Uses of Botulinum Toxin in Urology and Gynaecology
neuropathic bladder conditions detrusor overactivity detrusor sphincter dysenergia bladder overactivity painful bladder syndrome pelvic pain outflow obstruction symptoms urinary retention
10
Injecting Botulinum into the Bladder
100 units diluted with 10mls of normal saline given as 1 ml injections dose of units spare the trigone
11
Injecting Botulinum Toxin
Rigid cystoscope using GA day patient higher doses more precise Flexible cystoscope using LA outpatient clinic well tolerated
12
Injecting Botulinum toxin
13
Flexible Cystoscopy
14
Injection of Botulinum Toxin in the Bladder
15
Side Effects Very rare Contraindications no severe effects reported
minor effects dysphagia, diplopia, blurred vision periheral muscle weakness Contraindications pre-existing neuromuscular conditions
16
Bladder Overactivity Collection of Symptoms
urgency urge incontinence frequency nocturia Very common problem especially in the elderly
17
Treating Bladder Overactivity
Treatment oxybutynin imipramine very expensive anticholinergics major surgery Now can offer Botulinum toxin if medications do not work
18
Choosing the Botox Patient
Symptoms of urgency, urge incontinence No UTIs Failed/intolerant oxybutynin No voiding dysfunction Urodynamics
19
Urodynamics showing Detrusor Overactivity
20
Treating Bladder Overactivity with Botulinum Toxin
Effects take 1-3 weeks Check residual if symptoms worsen Retention improves after 6-8 weeks UTIs Effects last 6-16 months Can repeat treatment
21
Literature Results 100 units 200 units Urge incontinence resolved 86%
Nocturia 4 – 1.5 Frequency 14 – 7 Retention 4% 200 units Urge incontinence resolved 50% Nocturia Frequency 15 – 8 Retention 37%
22
Repeat Treatments Effect on smooth muscle Repeat treatments results in
fades after 6-12 months axonal regeneration Repeat treatments results in same response antibodies to Type A very uncommon
23
Neurogenic Detrusor Overactivity
Occurs in spinal cord injury multiple sclerosis Parkinson’s post-stroke
24
Neurogenic Detrusor Overactivity
25
Neurogenic Detrusor Overactivity
10 unit injections Use a higher dose: 300 units Patients already self-catheterising
26
Painful Bladder Syndrome
Two studies one effective one ineffective Tried two patients with mixed effect Raises questions as to how Botulinum toxin works
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.